Marshall Wace’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-47,808
| Closed | -$445K | – | 2737 |
|
|
2024
Q1 | $445K | Sell |
47,808
-26,935
| -36% | -$251K | ﹤0.01% | 1737 |
|
|
2023
Q4 | $631K | Sell |
74,743
-133,819
| -64% | -$1.13M | ﹤0.01% | 1357 |
|
|
2023
Q3 | $1.62M | Sell |
208,562
-260,715
| -56% | -$2.02M | ﹤0.01% | 1123 |
|
|
2023
Q2 | $5.37M | Buy |
469,277
+402,280
| +600% | +$4.61M | 0.01% | 848 |
|
|
2023
Q1 | $517K | Buy |
+66,997
| New | +$517K | ﹤0.01% | 1637 |
|
|
2022
Q4 | – | Sell |
-189,736
| Closed | -$1.12M | – | 2874 |
|
|
2022
Q3 | $1.12M | Buy |
+189,736
| New | +$1.12M | ﹤0.01% | 1760 |
|
|
2022
Q2 | – | Sell |
-305,445
| Closed | -$2.33M | – | 3219 |
|
|
2022
Q1 | $2.33M | Sell |
305,445
-136,436
| -31% | -$1.04M | ﹤0.01% | 1570 |
|
|
2021
Q4 | $1.2M | Buy |
+441,881
| New | +$1.2M | ﹤0.01% | 1844 |
|
|
2021
Q3 | – | Sell |
-21,852
| Closed | -$90K | – | 2872 |
|
|
2021
Q2 | $90K | Sell |
21,852
-10,843
| -33% | -$44.7K | ﹤0.01% | 2016 |
|
|
2021
Q1 | $154K | Buy |
+32,695
| New | +$154K | ﹤0.01% | 1980 |
|
|
2020
Q3 | – | Sell |
-95,954
| Closed | -$1.21M | – | 1916 |
|
|
2020
Q2 | $1.21M | Sell |
95,954
-98,490
| -51% | -$1.24M | 0.01% | 916 |
|
|
2020
Q1 | $1.78M | Buy |
+194,444
| New | +$1.78M | 0.02% | 658 |
|
|
2019
Q4 | – | Sell |
-42,141
| Closed | -$725K | – | 2039 |
|
|
2019
Q3 | $725K | Buy |
+42,141
| New | +$725K | 0.01% | 976 |
|
|
2018
Q4 | – | Sell |
-58,749
| Closed | -$1.11M | – | 1827 |
|
|
2018
Q3 | $1.11M | Buy |
+58,749
| New | +$1.11M | 0.01% | 787 |
|